News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Activist Investor Ackman Says Allergan Inc. (AGN) Investors Back Takeover At $180 A Share


6/9/2014 9:45:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Allergan Inc shareholders have told activist investor William Ackman, who along with Valeant Pharmaceuticals is trying to buy Botox maker Allergan Inc that they would support a deal at $180 per share, Ackman said Monday.

Valeant and Ackman, who owns almost 10 percent of Allergan through Pershing Square Capital Management, are in the midst of a hostile takeover battle for Allergan that began with a joint bid on April 22.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES